Correspondence 0001493152-24-017126 from LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Date: April 30, 2024 · CIK: 0001335105 · Accession: 0001493152-24-017126

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-278874

Date

April 30, 2024

Author

LIXTE

Form

CORRESP

Company

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Letter

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

East Colorado Boulevard, Suite 180

Pasadena, California 91101

April 30, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, D.C. 20549

Re: Lixte Biotechnology Holdings, Inc.

Registration Statement on Form S-3

Filed April 23, 2024

File No. 333-278874

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Lixte Biotechnology Holdings, Inc., a Delaware corporation, respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on Thursday, May 2, 2024, or as soon thereafter as is practicable. Please call our counsel, David Ficksman of TroyGould PC, at 818 469 4200 to provide notice of effectiveness.

Very
truly yours,
LIXTE
BIOTECHNOLOGY HOLDINGS, INC.

Show Raw Text

CORRESP
1
filename1.htm

LIXTE
BIOTECHNOLOGY HOLDINGS, INC.

680
East Colorado Boulevard, Suite 180

Pasadena,
California 91101

April 30, 2024

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
D.C. 20549

    Re:
    Lixte
    Biotechnology Holdings, Inc.

    Registration
    Statement on Form S-3

    Filed
    April 23, 2024

    File
    No. 333-278874

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, Lixte Biotechnology Holdings, Inc., a Delaware corporation,
respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will
become effective at 4:00 p.m., Eastern Time, on Thursday, May 2, 2024, or as soon thereafter as is practicable. Please call our
counsel, David Ficksman of TroyGould PC, at 818 469 4200 to provide notice of effectiveness.

    Very
    truly yours,

    LIXTE
    BIOTECHNOLOGY HOLDINGS, INC.

    By:
    /s/
    Bastiaan van der Baan

    Bastiaan
    van der Baan

    Chief
     Executive Officer

SecProbe.io